Megan A Rech, PharmD, MSc
@meganarech.bsky.social
Wife & boy mama 👦👦| Research health scientist | EM pharmacist 🚑 | Co-founder empharmnet.org | Inaugural chair AEMP 🚨 (SAEM.org/AEMP)
Pinned
🚨 @acepnation.bsky.social ED Accreditation Criteria are out & thanks to @saemonline.bsky.social & #AEMP, a pharmacist is now required for all Level 1 & Level 2 sites - THIS is the work we're doing to advance EM pharmacy practice 🙌
www.acep.org/siteassets/s...
www.acep.org/siteassets/s...
Reposted by Megan A Rech, PharmD, MSc
It was such a joy meeting the University of Toledo #RxSTAT Chapter at the ACCP Annual Meeting!
They’re already building the future of emergency medicine pharmacy, and I can’t wait to see all that they accomplish next.
@saemaemp.bsky.social @meganarech.bsky.social
They’re already building the future of emergency medicine pharmacy, and I can’t wait to see all that they accomplish next.
@saemaemp.bsky.social @meganarech.bsky.social
October 21, 2025 at 4:23 PM
It was such a joy meeting the University of Toledo #RxSTAT Chapter at the ACCP Annual Meeting!
They’re already building the future of emergency medicine pharmacy, and I can’t wait to see all that they accomplish next.
@saemaemp.bsky.social @meganarech.bsky.social
They’re already building the future of emergency medicine pharmacy, and I can’t wait to see all that they accomplish next.
@saemaemp.bsky.social @meganarech.bsky.social
💡 Need one more reason to love your friendly EM pharmacist? Check out this #EMPHARM_NET SR/MA:
⏰ EMP presence was associated with reduced mean DTN time by 14.6 minutes (95 % CI -18.1, −11.1 min)
Time for #AmericanStrokeAssociation to take notice?
⏰ EMP presence was associated with reduced mean DTN time by 14.6 minutes (95 % CI -18.1, −11.1 min)
Time for #AmericanStrokeAssociation to take notice?
August 19, 2025 at 9:22 PM
💡 Need one more reason to love your friendly EM pharmacist? Check out this #EMPHARM_NET SR/MA:
⏰ EMP presence was associated with reduced mean DTN time by 14.6 minutes (95 % CI -18.1, −11.1 min)
Time for #AmericanStrokeAssociation to take notice?
⏰ EMP presence was associated with reduced mean DTN time by 14.6 minutes (95 % CI -18.1, −11.1 min)
Time for #AmericanStrokeAssociation to take notice?
📣Have you heard of antiamyloid therapies for Alzheimer’s disease? They cause ADEs called ARIAs that are non-specific, typically require MRI, & can mimic stroke
⛔ Concomitant thrombolytics/anticoagulants are contraindicated
Learn more in our JAMA IM Clinical Insight 👇
⛔ Concomitant thrombolytics/anticoagulants are contraindicated
Learn more in our JAMA IM Clinical Insight 👇
Antiamyloid therapies for #Alzheimer disease slow cognitive decline but pose serious adverse effects like amyloid-related imaging abnormalities.
ja.ma/3V32mjt
ja.ma/3V32mjt
August 18, 2025 at 8:34 PM
📣Have you heard of antiamyloid therapies for Alzheimer’s disease? They cause ADEs called ARIAs that are non-specific, typically require MRI, & can mimic stroke
⛔ Concomitant thrombolytics/anticoagulants are contraindicated
Learn more in our JAMA IM Clinical Insight 👇
⛔ Concomitant thrombolytics/anticoagulants are contraindicated
Learn more in our JAMA IM Clinical Insight 👇
Real-🌎 data in Veterans with fXaI-related ICH treated w/ andexanet alfa (AA; n=129) or 4F-PCC ( n=221)
🔷Propensity matched
🔷No difference in 90-day mortality
🔷⬆️30-day thrombotic events w/ AA (11.4 % vs. 2.4 %, p < 0.01)
Free 👉https://www.sciencedirect.com/science/article/pii/S073567572500498X
🔷Propensity matched
🔷No difference in 90-day mortality
🔷⬆️30-day thrombotic events w/ AA (11.4 % vs. 2.4 %, p < 0.01)
Free 👉https://www.sciencedirect.com/science/article/pii/S073567572500498X
Andexanet alfa increases 30-day thrombotic events relative to four-factor prothrombin complex concentrate for factor Xa inhibitors-related intracerebral hemorrhage in veterans
Two hemostatic agents are commonly used to reverse factor Xa (fXa) inhibitor-related intracranial hemorrhage (ICH): andexanet alfa (AA) or 4-factor pr…
www.sciencedirect.com
July 23, 2025 at 3:16 PM
Real-🌎 data in Veterans with fXaI-related ICH treated w/ andexanet alfa (AA; n=129) or 4F-PCC ( n=221)
🔷Propensity matched
🔷No difference in 90-day mortality
🔷⬆️30-day thrombotic events w/ AA (11.4 % vs. 2.4 %, p < 0.01)
Free 👉https://www.sciencedirect.com/science/article/pii/S073567572500498X
🔷Propensity matched
🔷No difference in 90-day mortality
🔷⬆️30-day thrombotic events w/ AA (11.4 % vs. 2.4 %, p < 0.01)
Free 👉https://www.sciencedirect.com/science/article/pii/S073567572500498X
📣Have you heard of antiamyloid therapies for AD? They cause ADEs called ARIAs that are non-specific, typically require MRI & can mimic stroke
⛔ Concomitant thrombolytics/anticoagulants are contraindicated
Learn more in our JAMA IM Clinical Insight 👉 jamanetwork.com/journals/jam...
⛔ Concomitant thrombolytics/anticoagulants are contraindicated
Learn more in our JAMA IM Clinical Insight 👉 jamanetwork.com/journals/jam...
Recognizing and Managing Adverse Effects of Antiamyloid Therapies
This clinical insight discusses the diagnosis and management of adverse effects of antiamyloid therapies and what medications require consideration or avoidance.
jamanetwork.com
June 23, 2025 at 5:39 PM
📣Have you heard of antiamyloid therapies for AD? They cause ADEs called ARIAs that are non-specific, typically require MRI & can mimic stroke
⛔ Concomitant thrombolytics/anticoagulants are contraindicated
Learn more in our JAMA IM Clinical Insight 👉 jamanetwork.com/journals/jam...
⛔ Concomitant thrombolytics/anticoagulants are contraindicated
Learn more in our JAMA IM Clinical Insight 👉 jamanetwork.com/journals/jam...
Reposted by Megan A Rech, PharmD, MSc
AOC: “It is absolutely and clearly grounds for impeachment.”
June 22, 2025 at 2:03 AM
AOC: “It is absolutely and clearly grounds for impeachment.”
Reposted by Megan A Rech, PharmD, MSc
Impeach the motherfucker.
June 22, 2025 at 2:46 AM
Impeach the motherfucker.
Reposted by Megan A Rech, PharmD, MSc
Just to be crystal clear: bombing Iran is completely illegal.
June 22, 2025 at 2:47 AM
Just to be crystal clear: bombing Iran is completely illegal.
Nothing has made me love clinical pharmacy practice more than leaving it full time, taking some time away and coming back part time. This model doesn’t scale well but it makes me hopeful nonetheless.
May 29, 2025 at 11:43 PM
Nothing has made me love clinical pharmacy practice more than leaving it full time, taking some time away and coming back part time. This model doesn’t scale well but it makes me hopeful nonetheless.
Leaving @saemonline.bsky.social @saemaemp.bsky.social Annual Meeting with an immense gratitude for all of the individuals who built up AEMP into an Academy & continuing to trail-blaze to advance EM pharmacy practice. Can’t wait to do it again next year in Atlanta! #AEMP25 #AEMPlify
May 16, 2025 at 11:25 PM
Leaving @saemonline.bsky.social @saemaemp.bsky.social Annual Meeting with an immense gratitude for all of the individuals who built up AEMP into an Academy & continuing to trail-blaze to advance EM pharmacy practice. Can’t wait to do it again next year in Atlanta! #AEMP25 #AEMPlify
Reposted by Megan A Rech, PharmD, MSc
💀 Tox cases continue!
🤩 So happy to see such a full house this afternoon!
#AEMP25 #AEMPlify @meganarech.bsky.social
🤩 So happy to see such a full house this afternoon!
#AEMP25 #AEMPlify @meganarech.bsky.social
May 15, 2025 at 5:52 PM
💀 Tox cases continue!
🤩 So happy to see such a full house this afternoon!
#AEMP25 #AEMPlify @meganarech.bsky.social
🤩 So happy to see such a full house this afternoon!
#AEMP25 #AEMPlify @meganarech.bsky.social
Great turnout at the @saemaemp.bsky.social happy hour last night planned by AEMP Membership Committee! Thanks @empoisonpharmd.bsky.social for wrangling everyone for the picture #AEMP25 #AEMPlify
May 15, 2025 at 5:27 PM
Great turnout at the @saemaemp.bsky.social happy hour last night planned by AEMP Membership Committee! Thanks @empoisonpharmd.bsky.social for wrangling everyone for the picture #AEMP25 #AEMPlify
The IGNITE! Resident Pearl session is on @saemonline.bsky.social @saemaemp.bsky.social #AEMPlify #AEMP25
May 14, 2025 at 6:10 PM
The IGNITE! Resident Pearl session is on @saemonline.bsky.social @saemaemp.bsky.social #AEMPlify #AEMP25
Congrats to @cbthepharmd.bsky.social on her early career @agem-saem.bsky.social award! First @saemaemp.bsky.social member to trail blaze in this space! #AEMPlify #AEMP25
May 14, 2025 at 6:03 PM
Congrats to @cbthepharmd.bsky.social on her early career @agem-saem.bsky.social award! First @saemaemp.bsky.social member to trail blaze in this space! #AEMPlify #AEMP25
Reposted by Megan A Rech, PharmD, MSc
🎉 Big news from #SAEM25 -- AEMP is officially transitioning to an academy within SAEM!!
🥳 We are so excited for the opportunities this will offer us!
🥂 Thankful for all our members & the group of EM pharmacist leaders who made this possible!!
#AEMPlify #AEMP25 @saemonline.bsky.social
🥳 We are so excited for the opportunities this will offer us!
🥂 Thankful for all our members & the group of EM pharmacist leaders who made this possible!!
#AEMPlify #AEMP25 @saemonline.bsky.social
May 14, 2025 at 1:44 PM
🎉 Big news from #SAEM25 -- AEMP is officially transitioning to an academy within SAEM!!
🥳 We are so excited for the opportunities this will offer us!
🥂 Thankful for all our members & the group of EM pharmacist leaders who made this possible!!
#AEMPlify #AEMP25 @saemonline.bsky.social
🥳 We are so excited for the opportunities this will offer us!
🥂 Thankful for all our members & the group of EM pharmacist leaders who made this possible!!
#AEMPlify #AEMP25 @saemonline.bsky.social
So excited to announce that @saemaemp.bsky.social is officially the 9th @saemonline.bsky.social Academy! Thanks so everyone who worked so hard to get us to this point & continue to promote our mission of advancing EM pharmacy practice! So grateful to work with all of you!
May 14, 2025 at 1:51 PM
So excited to announce that @saemaemp.bsky.social is officially the 9th @saemonline.bsky.social Academy! Thanks so everyone who worked so hard to get us to this point & continue to promote our mission of advancing EM pharmacy practice! So grateful to work with all of you!
“What do you mean I don’t work with an emergency medicine pharmacist?”
(Let’s fix that in season 2! @hbomax.bsky.social @emrap.bsky.social)
(Let’s fix that in season 2! @hbomax.bsky.social @emrap.bsky.social)
May 6, 2025 at 10:49 PM
“What do you mean I don’t work with an emergency medicine pharmacist?”
(Let’s fix that in season 2! @hbomax.bsky.social @emrap.bsky.social)
(Let’s fix that in season 2! @hbomax.bsky.social @emrap.bsky.social)
Reposted by Megan A Rech, PharmD, MSc
Sen. Ossoff: Who out there in the American public is sitting at home demanding that we shut down cancer research and Alzheimer's research?
April 30, 2025 at 6:14 PM
Sen. Ossoff: Who out there in the American public is sitting at home demanding that we shut down cancer research and Alzheimer's research?
🔥 RCT of EM PharmD-led TOC program
💊 330 pts to ED w/ med-related events (MRE) w/ or w/o EMP TOC @ 72h
💊EMP group⬇️ ED visits for same MRE (3% v 22%) & overall ED visits, ⬇️ hospitalizations, more outpatient follow up
LOVE to see it!
jamanetwork.com/journals/jam...
💊 330 pts to ED w/ med-related events (MRE) w/ or w/o EMP TOC @ 72h
💊EMP group⬇️ ED visits for same MRE (3% v 22%) & overall ED visits, ⬇️ hospitalizations, more outpatient follow up
LOVE to see it!
jamanetwork.com/journals/jam...
Emergency Department Visits for Medication-Related Events With vs Without Pharmacist Intervention
This randomized clinical trial assesses the efficacy of a pharmacist-led transition of care program in reducing emergency department visits related to the same medication-related event at 6 months com...
jamanetwork.com
April 28, 2025 at 9:18 PM
🔥 RCT of EM PharmD-led TOC program
💊 330 pts to ED w/ med-related events (MRE) w/ or w/o EMP TOC @ 72h
💊EMP group⬇️ ED visits for same MRE (3% v 22%) & overall ED visits, ⬇️ hospitalizations, more outpatient follow up
LOVE to see it!
jamanetwork.com/journals/jam...
💊 330 pts to ED w/ med-related events (MRE) w/ or w/o EMP TOC @ 72h
💊EMP group⬇️ ED visits for same MRE (3% v 22%) & overall ED visits, ⬇️ hospitalizations, more outpatient follow up
LOVE to see it!
jamanetwork.com/journals/jam...
Reposted by Megan A Rech, PharmD, MSc
Deaths from heart disease down 75%, that’s NIH.
Deaths from stroke down 75%, that’s NIH.
HIV/AIDS no longer a death sentence, that’s NIH.
99% of FDA approved drugs in the last decade, that’s NIH.
Please show this video to anyone who doesn’t understand why the NIH is so important.
Deaths from stroke down 75%, that’s NIH.
HIV/AIDS no longer a death sentence, that’s NIH.
99% of FDA approved drugs in the last decade, that’s NIH.
Please show this video to anyone who doesn’t understand why the NIH is so important.
April 28, 2025 at 5:20 PM
Deaths from heart disease down 75%, that’s NIH.
Deaths from stroke down 75%, that’s NIH.
HIV/AIDS no longer a death sentence, that’s NIH.
99% of FDA approved drugs in the last decade, that’s NIH.
Please show this video to anyone who doesn’t understand why the NIH is so important.
Deaths from stroke down 75%, that’s NIH.
HIV/AIDS no longer a death sentence, that’s NIH.
99% of FDA approved drugs in the last decade, that’s NIH.
Please show this video to anyone who doesn’t understand why the NIH is so important.
Reposted by Megan A Rech, PharmD, MSc
⁉️Which patients require reversal in warfarin associated GIB? We lack large RCTs to guide treatment.
Check out our retrospective study evaluating treatments in GIB
www.sciencedirect.com/science/arti...
Check out our retrospective study evaluating treatments in GIB
www.sciencedirect.com/science/arti...
Comparison of anticoagulation reversal strategies for warfarin associated acute gastrointestinal bleeding
Gastrointestinal bleeding (GIB) is a common complication associated with warfarin use. However, the optimal approach for anticoagulation reversal—whet…
www.sciencedirect.com
April 19, 2025 at 8:23 PM
⁉️Which patients require reversal in warfarin associated GIB? We lack large RCTs to guide treatment.
Check out our retrospective study evaluating treatments in GIB
www.sciencedirect.com/science/arti...
Check out our retrospective study evaluating treatments in GIB
www.sciencedirect.com/science/arti...